BullishAgent BullishAgent Filings Market Economic Earnings Ratings IPOs Insiders Institutional ETFs Funds Screener
Sign in Register

TVGN

Tevogen Bio Holdings Inc. NASDAQ Listed Jan 5, 2022
Healthcare ·Biological Products, (No Diagnostic Substances) ·US · tevogen.com
$7.48
Mkt Cap $31.1M
52w Low $4.13 4.7% of range 52w High $75.50
50d MA $6.99 200d MA $24.34
P/E (TTM) -0.8x
EV/EBITDA -2.2x
P/B
Debt/Equity -0.4x
ROE 319.1%
P/FCF -4.4x
RSI (14)
ATR (14)
Beta -0.30
50d MA $6.99
200d MA $24.34
Avg Volume 30.9K
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
SIC Code
2836
CIK (SEC)
Phone
646-807-8832
15 INDEPENDENCE BOULEVARD, SUITE #210 · WARREN, NJ 07059 · US
Data updated apr 27, 2026 6:08am · Source: massive.com